We hope to see you again soon!

You are now leaving Lundbeck UK's website (www.lundbeck.com/uk) for an external website. External links are provided as a resource to the viewer. Lundbeck UK are not responsible for the external website and its content.

UK-NOTPR-1010 | April 2022



Career Areas

We Need Every Brain in the Game

Throughout the value chain, we attract highly skilled professionals. We offer a collaborative work environment with dedicated colleagues and leaders, encourage continuous development and promote the balance that makes your life work.
Research and Development

Our research and development teams are dedicated to creating the most innovative and effective treatments for patients.

Commercial Operations

Our Commercial Operations team, including Sales, comprises around 3,300 people globally, and we have affiliates in 50+ countries.  

Corporate Functions

Our corporate functions provide dedicated support to our business within Finance, IT & Digitalisation, Legal, Compliance & Sustainability, Procurement, and Investor Relations to ensure business value.

Product Development and Supply

This is the core of our manufacturing unit. It offers significant opportunities for specialists within chemistry, production, supply chain, engineering, and maintenance. 


In Sales, we inform and educate key stakeholders, who are responsible for managing treatment with prescription drugs. Our activities towards healthcare professionals aim to ensure a correct understanding of our products and their use to support high quality patient care.

Saeed Moosa on working at Lundbeck

Delivering on a promise

placeholder image
Andrew Jackson on working at Lundbeck

Meet Andrew, UK Country Manager

Lili Dai on Working at Lundbeck

Meet Lili, Associate Marketing Director

More from Lundbeck

Our History

A long, proud story has led Lundbeck to where it is

Understanding Brain Diseases

The journey to brain health starts with understanding the diseases in the brain.

Our Value Chain

It takes about 10-15 years for a new drug to move through the pharmaceutical value

UK-NOTPR-1896 | May 2024